Johnson & Johnson [JNJ] stock is trading at $165.84, up 1.30%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The JNJ shares have gain 1.56% over the last week, with a monthly amount glided 0.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wolfe Research started tracking the stock with Outperform rating on November 15, 2024, and set its price target to $190. On July 23, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $150 on the stock. HSBC Securities upgraded its rating to a Buy but $170 remained the price target by the analyst firm on April 18, 2024. Wells Fargo downgraded its rating to Equal Weight for this stock on December 13, 2023, and downed its price target to $163. In a note dated December 01, 2023, UBS upgraded an Buy rating on this stock and boosted its target price from $167 to $180.
Johnson & Johnson [JNJ] stock has fluctuated between $140.68 and $169.99 over the past year. Currently, Wall Street analysts expect the stock to reach $177.13 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $165.84 at the most recent close of the market. An investor can expect a potential return of 6.81% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
Johnson & Johnson [NYSE:JNJ] reported sales of 88.82B for the trailing twelve months, which represents a growth of 5.27%. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.2 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 164.50 points at the first support level, and at 163.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 166.90, and for the 2nd resistance point, it is at 167.97.
Ratios To Look Out For
For context, Johnson & Johnson’s Current Ratio is 1.11. As well, the Quick Ratio is 0.86, while the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 4.50, the price to book ratio is 5.58 and price to earnings (TTM) ratio is 28.61.
Transactions by insiders
Recent insider trading involved Decker Robert J, VP Corporate Controller, that happened on Feb 25 ’25 when 6999.0 shares were sold. Officer, Decker Robert J completed a deal on Feb 25 ’25 to buy 6999.0 shares. Meanwhile, EVP, WW Chair, MedTech Schmid Timothy sold 403.0 shares on Feb 18 ’25.
